527 related articles for article (PubMed ID: 10973320)
1. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Kureishi Y; Luo Z; Shiojima I; Bialik A; Fulton D; Lefer DJ; Sessa WC; Walsh K
Nat Med; 2000 Sep; 6(9):1004-10. PubMed ID: 10973320
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells.
Skaletz-Rorowski A; Lutchman M; Kureishi Y; Lefer DJ; Faust JR; Walsh K
Cardiovasc Res; 2003 Jan; 57(1):253-64. PubMed ID: 12504836
[TBL] [Abstract][Full Text] [Related]
3. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
5. Statin therapy and angiogenesis.
Skaletz-Rorowski A; Walsh K
Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
Llevadot J; Murasawa S; Kureishi Y; Uchida S; Masuda H; Kawamoto A; Walsh K; Isner JM; Asahara T
J Clin Invest; 2001 Aug; 108(3):399-405. PubMed ID: 11489933
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice.
Huang PH; Chen JY; Chen CY; Chen JW; Lin SJ; Shih CC
J Vasc Surg; 2016 Oct; 64(4):1112-1120.e1. PubMed ID: 26830691
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
Laufs U; La Fata V; Plutzky J; Liao JK
Circulation; 1998 Mar; 97(12):1129-35. PubMed ID: 9537338
[TBL] [Abstract][Full Text] [Related]
9. The pro- and antiangiogenic effects of statins.
Skaletz-Rorowski A; Kureishi Y; Shiojima I; Walsh K
Semin Vasc Med; 2004 Nov; 4(4):395-400. PubMed ID: 15861320
[TBL] [Abstract][Full Text] [Related]
10. Molecular multitasking: statins lead to more arteries, less plaque.
Simons M
Nat Med; 2000 Sep; 6(9):965-6. PubMed ID: 10973306
[No Abstract] [Full Text] [Related]
11. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
[TBL] [Abstract][Full Text] [Related]
12. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.
Endres M; Laufs U; Huang Z; Nakamura T; Huang P; Moskowitz MA; Liao JK
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8880-5. PubMed ID: 9671773
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.
Wolfrum S; Dendorfer A; Schutt M; Weidtmann B; Heep A; Tempel K; Klein HH; Dominiak P; Richardt G
J Cardiovasc Pharmacol; 2004 Sep; 44(3):348-55. PubMed ID: 15475833
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin increases the activity of endothelial nitric oxide synthase via enhancing phosphorylation.
Li X; Wang P; Xu X; Wang Y; Xia Y; Wang D
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):286-90. PubMed ID: 19513607
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells.
Wang J; Tokoro T; Matsui K; Higa S; Kitajima I
Life Sci; 2005 Mar; 76(19):2257-68. PubMed ID: 15733940
[TBL] [Abstract][Full Text] [Related]
16. Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia.
Ikeda Y; Tajima S; Izawa-Ishizawa Y; Kihira Y; Ishizawa K; Yoshida S; Aihara K; Tsuchiya K; Tamaki T
J Cardiovasc Pharmacol; 2013 May; 61(5):423-9. PubMed ID: 23364610
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin enhances myocardial angiogenesis induced by vascular endothelial growth factor gene transfer.
Siddiqui AJ; Gustafsson T; Fischer H; Widegren U; Hao X; Mansson-Broberg A; Grinnemo KH; Dellgren G; Sylvén C
J Mol Cell Cardiol; 2004 Dec; 37(6):1235-44. PubMed ID: 15572054
[TBL] [Abstract][Full Text] [Related]
18. Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?
Ungvari Z; Pacher P; Csiszar A
Med Hypotheses; 2002 Jan; 58(1):85-6. PubMed ID: 11863404
[TBL] [Abstract][Full Text] [Related]
19. Double-edged role of statins in angiogenesis signaling.
Urbich C; Dernbach E; Zeiher AM; Dimmeler S
Circ Res; 2002 Apr; 90(6):737-44. PubMed ID: 11934843
[TBL] [Abstract][Full Text] [Related]
20. Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.
Harris MB; Blackstone MA; Sood SG; Li C; Goolsby JM; Venema VJ; Kemp BE; Venema RC
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H560-6. PubMed ID: 15087285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
